141 related articles for article (PubMed ID: 33624546)
1. Pseudocarcinomatous Mesothelioma: A Hitherto Unreported Presentation closely simulating primary lung cancer.
Rossi G; Caroli G; Caruso D; Stella F; Davoli F
Int J Surg Pathol; 2021 Oct; 29(7):775-779. PubMed ID: 33624546
[TBL] [Abstract][Full Text] [Related]
2. Diffuse intrapulmonary mesothelioma mimicking pulmonary lepidic adenocarcinoma: a rare case report and review of the literature.
RanYue W; ChunYan W; Likun H; LiPing Z; JieLu L; ZhengWei D
Diagn Pathol; 2023 May; 18(1):64. PubMed ID: 37194050
[TBL] [Abstract][Full Text] [Related]
3. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
4. Case reports of primary pulmonary adenocarcinoma with pleural spread: so-called pseudomesotheliomatous adenocarcinoma.
Saito R; Kasajima A; Taniuchi S; Fujishima F; Ishida K; Nakamura Y; Yamanda S; Takahashi T; Hitomi H; Murakami K; Watanabe M; Sasano H
Pathol Int; 2012 Oct; 62(10):709-15. PubMed ID: 23005599
[TBL] [Abstract][Full Text] [Related]
5. Calretinin-expressing lung adenocarcinoma: Distinct characteristics of advanced stages, smoker-type features, and rare expression of other mesothelial markers are useful to differentiate epithelioid mesothelioma.
Matsuda M; Ninomiya H; Wakejima R; Inamura K; Okumura S; Mun M; Kitagawa M; Ishikawa Y
Pathol Res Pract; 2020 Mar; 216(3):152817. PubMed ID: 32008868
[TBL] [Abstract][Full Text] [Related]
6. [Clinical comparison of diffuse malignant mesothelioma of the pleura and pseudomesotheliomatous carcinoma of the lung for each case].
Yuasa H; Tomoyasu M
Kyobu Geka; 1999 Sep; 52(10):836-9. PubMed ID: 10478545
[TBL] [Abstract][Full Text] [Related]
7. Coalescent pleural malignant mesothelioma and adenocarcinoma of the lung, involving only minor asbestos exposure.
Tsuzuki T; Ninomiya H; Natori Y; Ishikawa Y
Pathol Int; 2008 Jul; 58(7):451-5. PubMed ID: 18577116
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal Caveolin 1 Expression in the Differential Diagnosis of Malignant Pleural Mesothelioma and Pulmonary Adenocarcinoma: Is it Useful?
Bozdag Z; Tutar E; Dizibuyuk OF; Bakir K
Pathol Oncol Res; 2020 Jul; 26(3):1651-1656. PubMed ID: 31512057
[TBL] [Abstract][Full Text] [Related]
9. Unusual intraparenchymal growth patterns of malignant pleural mesothelioma.
Nind NR; Attanoos RL; Gibbs AR
Histopathology; 2003 Feb; 42(2):150-5. PubMed ID: 12558747
[TBL] [Abstract][Full Text] [Related]
10. Synchronous occurrence of pulmonary adenocarcinoma and pleural diffuse malignant mesothelioma.
Imenpour H; Ivaldi GP; Brianti A; Pastorino G; Biggi S; Auriati L; Simonassi C
Pathologica; 2013 Dec; 105(6):353-6. PubMed ID: 24730341
[TBL] [Abstract][Full Text] [Related]
11. Novel marker D2-40, combined with calretinin, CEA, and TTF-1: an optimal set of immunodiagnostic markers for pleural mesothelioma.
Mimura T; Ito A; Sakuma T; Ohbayashi C; Yoshimura M; Tsubota N; Okita Y; Okada M
Cancer; 2007 Mar; 109(5):933-8. PubMed ID: 17279584
[TBL] [Abstract][Full Text] [Related]
12. Sarcomatoid Mesothelioma: A Clinicopathological and Immunohistochemical Study of 64 Cases.
Oramas DM; Zaleski M; Moran CA
Int J Surg Pathol; 2021 Dec; 29(8):820-825. PubMed ID: 33939493
[TBL] [Abstract][Full Text] [Related]
13. Clinical feature of diagnostic challenging cases for pleural biopsy in patient with malignant pleural mesothelioma.
Hashimoto M; Sato A; Kuroda A; Nakamura A; Nakamichi T; Kondo N; Yuki M; Nabeshima K; Tsujimura T; Hasegawa S
Gen Thorac Cardiovasc Surg; 2020 Aug; 68(8):820-827. PubMed ID: 31981139
[TBL] [Abstract][Full Text] [Related]
14. Squamous differentiation in surgically resected malignant pleural mesothelioma with neoadjuvant chemotherapy.
Yotsukura M; Motoi N; Yoshida A; Yoshida Y; Nakagawa K; Watanabe SI
Pathol Int; 2021 Oct; 71(10):692-696. PubMed ID: 34255921
[TBL] [Abstract][Full Text] [Related]
15. Malignant mesothelioma without asbestos exposure diagnosed during EGFR-TKI treatment of lung adenocarcinoma: A case report.
Niu X; Zhou C; Hu A; Su L; Lin D; Han H; Lu Y
Cancer Treat Res Commun; 2021; 27():100345. PubMed ID: 33640705
[TBL] [Abstract][Full Text] [Related]
16. Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma.
Kushitani K; Amatya VJ; Okada Y; Katayama Y; Mawas AS; Miyata Y; Okada M; Inai K; Kishimoto T; Takeshima Y
Histopathology; 2017 Feb; 70(3):375-384. PubMed ID: 27589012
[TBL] [Abstract][Full Text] [Related]
17. Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma.
Takeshima Y; Amatya VJ; Kushitani K; Kaneko M; Inai K
Histopathology; 2009 May; 54(6):667-76. PubMed ID: 19438742
[TBL] [Abstract][Full Text] [Related]
18. Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma.
Carbone M; Shimizu D; Napolitano A; Tanji M; Pass HI; Yang H; Pastorino S
Oncotarget; 2016 Sep; 7(37):59314-59321. PubMed ID: 27447750
[TBL] [Abstract][Full Text] [Related]
19. Metastasis of Sarcomatoid Malignant Mesothelioma With
Chen KB; Huang YJ; Huang Y; Wu ZW; Jin XL; Zhang H; Xiang XP; Chen L; Chen L
Int J Surg Pathol; 2021 Dec; 29(8):856-863. PubMed ID: 33729861
[TBL] [Abstract][Full Text] [Related]
20. Amelanotic Malignant Melanoma with Dense Pleural Thickening Mimicking Malignant Mesothelioma.
Saraya T; Fujiwara M; Morita K; Watanabe T; Ogawa Y; Takizawa H; Light RW
Intern Med; 2019 Apr; 58(7):969-972. PubMed ID: 30449771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]